Trial Profile
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetes
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIAB-therapy
- 22 Jul 2012 Actual initiation date (Dec 2011) added as reported by University Hospital Medical Information Network - Japan.
- 06 Dec 2011 New trial record